Terms: = Leukemia AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
10664 results:
1. Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.
Warfvinge R; Geironson Ulfsson L; Dhapola P; Safi F; Sommarin M; Soneji S; Hjorth-Hansen H; Mustjoki S; Richter J; Thakur RK; Karlsson G
Elife; 2024 Nov; 12():. PubMed ID: 39503729
[TBL] [Abstract] [Full Text] [Related]
2. A large cohort from an immunology reference center and an algorithm for the follow-up of chronic neutropenia.
Caka C; Ergenoğlu DN; Sinanoğlu N; Maslak IC; Bildik HN; Çiçek B; Esenboga S; Tezcan I; Cagdas D
J Clin Immunol; 2024 Nov; 45(1):38. PubMed ID: 39499404
[TBL] [Abstract] [Full Text] [Related]
3.
Wang JN; Ye B; Cheng F; Yang L; Hu Y; Zheng G; Cai Z; Yu J; Wu W
Hematology; 2024 Dec; 29(1):2423324. PubMed ID: 39499083
[TBL] [Abstract] [Full Text] [Related]
4. Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study.
Tanguay M; Roy J; Su J; Gul E; Reece D; Venner CP; White D; Chu MP; Jimenez-Zepada VH; Song K; Mccurdy A; Mian H; Sebag M; Bergstrom D; Stakiw J; Reiman A; Kotb R; Aslam M; Kaedbey R; Louzada M; LeBlanc R
Cancer Med; 2024 Nov; 13(21):e70332. PubMed ID: 39499045
[TBL] [Abstract] [Full Text] [Related]
5. [Fluorescence Quantitative PCR Detection of
Cheng HC; Li S; Wang DZ; Liu Y; Gong TJ; Ma J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1377-1380. PubMed ID: 39479819
[TBL] [Abstract] [Full Text] [Related]
6. [Halving Time of
Yang L; Cao LX; Ren HJ; Han YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1349-1355. PubMed ID: 39479815
[TBL] [Abstract] [Full Text] [Related]
7. [Association between Early Minimal Residual Disease Detected by Flow Cytometry and Prognosis in Children with Acute Myeloid leukemia: A Clinical Retrospective Study].
Lu WJ; Xiong H; Yang L; Long F; Chen Z; Tao F; Sun M; Wang Z; Luo LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1343-1348. PubMed ID: 39479814
[TBL] [Abstract] [Full Text] [Related]
8. Binding of a Drug (Colchicine) to L-Asparaginase Enzyme Using Multispectroscopic, Thermodynamics, and Simulation Studies: Possible Implication in Acute Lymphoblastic leukemia treatment.
Abdullah EM; Ataya FS; Rehman MT; Arshad M; Al Kheraif AA; Al-Twaijry N; Alshammari AH; AlAjmi MF; Alokail MS; Khan MS
Luminescence; 2024 Nov; 39(11):e70000. PubMed ID: 39478354
[TBL] [Abstract] [Full Text] [Related]
9. Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation.
Zhang C; Wang X; Yi H; Wang Y; Yan Z; Zhou J; Yang T; Liang A; Wang Z; Ma Y; Wen Q; Gao L; Gao L; Kong P; Tan X; Jiang E; Zhang X
J Hematol Oncol; 2024 Oct; 17(1):103. PubMed ID: 39468581
[TBL] [Abstract] [Full Text] [Related]
10. Exploring causal correlations between inflammatory cytokines and coronary heart disease: A Mendelian randomization study.
Lv L; Guo Y; Zheng Z; Li B
Medicine (Baltimore); 2024 Oct; 103(41):e39789. PubMed ID: 39465855
[TBL] [Abstract] [Full Text] [Related]
11. Combined targeting of GPX4 and bcr-abl tyrosine kinase selectively compromises bcr-abl+ leukemia stem cells.
Zeng C; Nie D; Wang X; Zhong S; Zeng X; Liu X; Qiu K; Peng X; Zhang W; Chen S; Zha X; Chen C; Chen Z; Wang W; Li Y
Mol Cancer; 2024 Oct; 23(1):240. PubMed ID: 39465372
[TBL] [Abstract] [Full Text] [Related]
12. The synergistic effect of miR-203 and cytarabine on the inhibition of cell proliferation and induction of apoptosis in chronic myelogenous leukemia cells.
Qi S; Huang J; Long R
Pak J Pharm Sci; 2024 Sep; 37(5):1019-1025. PubMed ID: 39460968
[TBL] [Abstract] [Full Text] [Related]
13. Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid leukemia.
Kusaba K; Watanabe T; Kidoguchi K; Yamamoto Y; Tomoda A; Hoshiko T; Kojima N; Nakata S; Kimura S
Int J Mol Sci; 2024 Oct; 25(20):. PubMed ID: 39456874
[TBL] [Abstract] [Full Text] [Related]
14. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient.
Özalp YC; Shehabie H; Tekin MG; Kaya SY; Beköz HS; Maral S; Sevindik ÖG; Kaynar L
BMC Infect Dis; 2024 Oct; 24(1):1201. PubMed ID: 39448907
[TBL] [Abstract] [Full Text] [Related]
15. New abl1 Kinase Domain Mutations in bcr::abl1-Positive Acute Lymphoblastic leukemia.
Li Z; Peng D; Deng J; Xiong L; Yin P; Hu J; Qian C; Yao L; Yin H; Hong M; Wu Q
Cancer Med; 2024 Oct; 13(20):e70317. PubMed ID: 39440695
[TBL] [Abstract] [Full Text] [Related]
16. Determination of Serum Myeloperoxidase (MPO) and lactate dehydrogenase (LDH) as a tumour Marker in Chronic Myeloid Leukaemia (CML).
Wahhab Ali KA; Ahmed AA; Mohammed ST
J Pak Med Assoc; 2024 Oct; 74(10 (Supple-8)):S283-S286. PubMed ID: 39434323
[TBL] [Abstract] [Full Text] [Related]
17. Insights into existing and futuristic treatment approach for chronic myeloid leukaemia.
Tyagi S; Singh A; Sharma N; Chaturvedi R; Kushwaha HR
Indian J Med Res; 2024 May; 159(5):455-467. PubMed ID: 39382408
[TBL] [Abstract] [Full Text] [Related]
18. Psychiatric disorders among survivors of childhood acute lymphoblastic leukemia in Denmark and Sweden.
Sørensen GV; Mogensen H; Holmqvist AS; Kenborg L; Pedersen C; Nielsen TT; Talbäck M; Erdmann F; Ifversen M; Feychting M; Schmiegelow K; Heyman MM; Winther JF; Hasle H; Frederiksen LE
Pediatr Blood Cancer; 2024 Dec; 71(12):e31361. PubMed ID: 39375822
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones.
Ianevski A; Nader K; Driva K; Senkowski W; Bulanova D; Moyano-Galceran L; Ruokoranta T; Kuusanmäki H; Ikonen N; Sergeev P; Vähä-Koskela M; Giri AK; Vähärautio A; Kontro M; Porkka K; Pitkänen E; Heckman CA; Wennerberg K; Aittokallio T
Nat Commun; 2024 Oct; 15(1):8579. PubMed ID: 39362905
[TBL] [Abstract] [Full Text] [Related]
20. Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Wang ES; Issa GC; Erba HP; Altman JK; Montesinos P; DeBotton S; Walter RB; Pettit K; Savona MR; Shah MV; Kremyanskaya M; Baer MR; Foran JM; Schiller G; Adès L; Heiblig M; Berthon C; Peterlin P; Rodríguez-Arbolí E; Salamero O; Patnaik MM; Papayannidis C; Grembecka J; Cierpicki T; Clegg B; Ray J; Linhares BM; Nie K; Mitra A; Ahsan JM; Tabachri M; Soifer HS; Corum D; Leoni M; Dale S; Fathi AT
Lancet Oncol; 2024 Oct; 25(10):1310-1324. PubMed ID: 39362248
[TBL] [Abstract] [Full Text] [Related]
[Next]